Reporting Date | Major Shareholder Name | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
05/10/2024 | BLACKROCK INC. | 5.44 M | $254.46 M | 1.70% | 8.10% |
05/15/2024 | DRIEHAUS CAPITAL MANAGEMENT LLC | 5.23 M | $244.64 M | 3.70% | 7.78% |
05/15/2024 | POINT72 ASSET MANAGEMENT, L.P. | 4.95 M | $231.69 M | 44.85% | 7.37% |
05/13/2024 | FMR LLC | 4.46 M | $208.94 M | 10.38% | 6.65% |
05/15/2024 | ECOR1 CAPITAL, LLC | 4.16 M | $194.51 M | 106.48% | 6.19% |
05/15/2024 | PRICE T ROWE ASSOCIATES INC /MD/ | 3.82 M | $178.97 M | 27.07% | 5.69% |
05/10/2024 | VANGUARD GROUP INC | 3.58 M | $167.35 M | 2.07% | 5.32% |
05/15/2024 | STATE STREET CORP | 3.26 M | $152.38 M | -8.66% | 4.85% |
05/15/2024 | PARADIGM BIOCAPITAL ADVISORS LP | 3.12 M | $146.27 M | 35.10% | 4.65% |
05/15/2024 | WELLINGTON MANAGEMENT GROUP LLP | 2.97 M | $139.10 M | -8.43% | 4.43% |
05/02/2024 | JENNISON ASSOCIATES LLC | 2.82 M | $131.90 M | 10.60% | 4.20% |
05/15/2024 | T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 2.65 M | $124.27 M | 9.81% | 3.95% |
05/15/2024 | JANUS HENDERSON GROUP PLC | 1.98 M | $92.53 M | 264.13% | 2.95% |
05/15/2024 | FIRST LIGHT ASSET MANAGEMENT, LLC | 1.69 M | $79.12 M | -14.97% | 2.52% |
05/15/2024 | PERCEPTIVE ADVISORS LLC | 1.48 M | $69.10 M | 17.58% | 2.20% |
05/13/2024 | GEODE CAPITAL MANAGEMENT, LLC | 1.40 M | $65.61 M | 3.60% | 2.09% |
05/17/2024 | ARTAL GROUP S.A. | 1.39 M | $65.09 M | 100.00% | 2.07% |
05/15/2024 | ORBIMED ADVISORS LLC | 1.39 M | $64.83 M | -16.93% | 2.06% |
05/15/2024 | CORMORANT ASSET MANAGEMENT, LP | 1.15 M | $53.83 M | 0.00% | 1.71% |
05/15/2024 | NOVO HOLDINGS A/S | 1.10 M | $51.43 M | -0.13% | 1.64% |
05/15/2024 | EVENTIDE ASSET MANAGEMENT, LLC | 1.06 M | $49.60 M | 0.00% | 1.58% |
05/09/2024 | LORD, ABBETT & CO. LLC | 964,568 | $45.15 M | 24.09% | 1.44% |
05/15/2024 | GOLDMAN SACHS GROUP INC | 864,107 | $40.45 M | 32.90% | 1.29% |
05/15/2024 | SATURN V CAPITAL MANAGEMENT LLC | 660,143 | $30.90 M | -16.13% | 0.98% |
05/17/2024 | IKARIAN CAPITAL, LLC | 643,751 | $30.13 M | -5.38% | 0.96% |
05/10/2024 | DIMENSIONAL FUND ADVISORS LP | 640,802 | $30.00 M | -2.90% | 0.95% |
05/15/2024 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 632,133 | $29.59 M | 100.00% | 0.94% |
05/15/2024 | LAURION CAPITAL MANAGEMENT LP | 630,182 | $29.50 M | 10.76% | 0.94% |
05/14/2024 | ENSIGN PEAK ADVISORS, INC | 621,507 | $29.09 M | 42.65% | 0.93% |
05/14/2024 | STEMPOINT CAPITAL LP | 619,789 | $29.01 M | 148.34% | 0.92% |
05/15/2024 | MORGAN STANLEY | 612,200 | $28.66 M | -5.56% | 0.91% |
05/14/2024 | NORTHERN TRUST CORP | 601,384 | $28.15 M | -0.17% | 0.90% |
05/13/2024 | NUVEEN ASSET MANAGEMENT, LLC | 553,739 | $25.91 M | -18.47% | 0.82% |
05/08/2024 | BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 542,708 | $25.40 M | -17.56% | 0.81% |
05/15/2024 | BIOIMPACT CAPITAL LLC | 480,588 | $22.50 M | 0.49% | 0.72% |
05/09/2024 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 478,532 | $22.40 M | 1.73% | 0.71% |
05/01/2024 | FIERA CAPITAL CORP | 475,510 | $22.26 M | 100.00% | 0.71% |
05/14/2024 | AFFINITY ASSET ADVISORS, LLC | 470,000 | $22.00 M | 5.12% | 0.70% |
05/09/2024 | FISHER ASSET MANAGEMENT, LLC | 436,023 | $20.41 M | -1.19% | 0.65% |
05/13/2024 | FRANKLIN RESOURCES INC | 413,209 | $19.34 M | 0.00% | 0.62% |
05/08/2024 | GW&K INVESTMENT MANAGEMENT, LLC | 388,066 | $18.17 M | -18.99% | 0.58% |
05/10/2024 | JPMORGAN CHASE & CO | 375,986 | $17.60 M | 303.83% | 0.56% |
05/15/2024 | BANK OF AMERICA CORP /DE/ | 357,142 | $16.72 M | 3.70% | 0.53% |
04/22/2024 | VIVO CAPITAL, LLC | 350,000 | $16.38 M | 0.00% | 0.52% |
05/15/2024 | INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 325,000 | $15.21 M | 62.50% | 0.48% |
05/15/2024 | CAPTION MANAGEMENT, LLC | 319,000 | $14.93 M | 324.20% | 0.48% |
05/15/2024 | DUQUESNE FAMILY OFFICE LLC | 309,000 | $14.46 M | 100.00% | 0.46% |
05/17/2024 | IKARIAN CAPITAL, LLC | 300,400 | $14.06 M | 100.00% | 0.45% |
04/25/2024 | BANK OF NEW YORK MELLON CORP | 296,478 | $13.88 M | -10.04% | 0.44% |
05/15/2024 | ROCK SPRINGS CAPITAL MANAGEMENT LP | 289,400 | $13.55 M | 100.00% | 0.43% |
A. During the previous two years, 256 institutional investors and hedge funds held shares of Crinetics Pharmaceuticals, Inc.. The most heavily invested institutionals were:
BlackRock Inc.: 5.44 M
DRIEHAUS CAPITAL MANAGEMENT LLC: 5.23 M
Point72 Asset Management, L.P.: 4.95 M
FMR LLC: 4.46 M
EcoR1 Capital, LLC: 4.16 M
PRICE T ROWE ASSOCIATES INC /MD/: 3.82 M
A. 119.75% of Crinetics Pharmaceuticals, Inc. stock is owned by institutional investors.
A. Institutional investors have bought a total of 96.19 M shares in the last 24 months. This purchase volume represents approximately $4.22 B in transactions.